FDA regs are not the only drivers of R&D costs

12/20/2012 | Forbes

FDA regulations are often blamed for the high cost of drug development, but drugmakers' business decisions may be the real culprits, writes Bernard Munos. FDA approval requires two successful Phase III trials, but drugmakers performed dozens of trials in support of blockbusters, whether to broaden the indication or in support of marketing, Munos writes. Moreover, the high failure rate of pre-approval Phase III trials seems to indicate that executives are pushing mediocre drug candidates through the pipeline, he writes.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
San Jose, CA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Systems Test - V&V Engineer - 14000008LS
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC